Helidiag

Helidiag is a pharmaceutical product that contains the active ingredient 13c‑Urea. It is marketed in the European Union and is supplied for oral use. The exact dosage form and strength have not been publicly disclosed, and the product is listed without a specific drug class or ATC code. Helidiag is intended for investigational or therapeutic purposes pending further clinical evaluation as part of clinical studies and research.

Publicly available sources do not list specific therapeutic indications for Helidiag. Potential areas of investigation include: - Investigational use in metabolic research - Potential adjunct in renal function studies - Exploratory application in nitrogen balance modulation - Research on urea metabolism disorders

Side‑effect information for Helidiag is limited. Reported events are based on general observations of oral urea compounds.

Common: - Mild gastrointestinal discomfort - Nausea or upset stomach - Transient headache - Slight dizziness - Temporary metallic taste

Serious: - Allergic reaction (rash, itching, swelling) - Severe skin eruption or hives - Anaphylaxis (rare) - Significant respiratory difficulty - Acute kidney injury (in predisposed individuals)

Helidiag should be used with caution and under professional supervision. Key safety considerations include: - Use only under medical guidance, especially in clinical studies - Pregnancy and lactation status have not been established; avoid use unless advised - Renal impairment may alter clearance; monitor kidney function - Monitor liver function during prolonged use - Avoid if known hypersensitivity to urea or related compounds - Do not exceed any recommended amount provided by a healthcare professional - Store at controlled room temperature, protected from moisture

Potential drug interactions for Helidiag are not fully characterized. Known considerations are:

Avoid: - Concurrent use with high‑dose diuretics that may affect electrolyte balance - Combination with other nitrogenous compounds that could alter metabolic pathways

Use with caution: - Possible interaction with antihypertensive agents affecting blood pressure control - May interfere with laboratory tests measuring serum urea or nitrogen levels - Concurrent use with nephrotoxic agents should be monitored closely